HealthUS FDA orders new eye-risk warnings for Ozempic and Zepbound
The US Food and Drug Administration told patients and healthcare providers on Monday that GLP-1 drugs used for weight loss and diabetes may be linked to a higher risk of a serious eye condition.
US FDA orders new eye-risk warnings for Ozempic and Zepbound
